LAB 8-K: Stock split
Filed with the SEC on · accession 0001140361-26-044934
LAB filed a 8-K (current report) with the SEC on Nov 19, 2026. Standard BioTools stockholders approved a reverse stock split at a ratio between 1-for-20 and 1-for-40, with the final ratio to be mutually agreed with Treeline Biosciences, Inc., in connection with the company's merger and renaming to Treeline Biosciences, Inc. Stockholders also approved the… The stock moved +7.7% by the first close after the filing.
Summary of the filing
Standard BioTools stockholders approved a reverse stock split at a ratio between 1-for-20 and 1-for-40, with the final ratio to be mutually agreed with Treeline Biosciences, Inc., in connection with the company's merger and renaming to Treeline Biosciences, Inc. Stockholders also approved the merger-related share issuance, post-closing equity incentive plan, ESPP, advisory compensation, and the Element Mass Cytometry divestiture.
Key details
How LAB stock reacted
Close before
$0.57
Nov 18, 2026
First close after
+7.67%
$0.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LAB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LAB?
Click hereFrequently asked questions
What did LAB file with the SEC on Nov 19, 2026?
LAB filed a 8-K (Stock split). Standard BioTools stockholders approved a reverse stock split at a ratio between 1-for-20 and 1-for-40, with the final ratio to be mutually agreed with Treeline Biosciences, Inc., in connection with the company's merger and renaming to Treeline Biosciences, Inc. Stockholders also approved the merger-related share issuance, post-closing equity incentive plan, ESPP, advisory compensation, and the Element Mass Cytometry divestiture.
What does a stock split mean for LAB stock?
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did LAB stock react to this filing?
LAB closed at $0.57 before the filing and $0.61 on Nov 19, 2026 (+7.67%).
Other LAB SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 8-K · Legal settlementNov 16, 2026
- 10-Q · SEC filingNov 3, 2026
- 8-K · DivestitureNov 3, 2026
- 424B3 · AcquisitionOct 30, 2026
- 424B3 · AcquisitionOct 21, 2026
- EFFECT · Shelf registrationOct 21, 2026
- S-4 · SEC filingOct 21, 2026
- S-4 · SEC filingOct 9, 2026
- 8-K · DivestitureOct 5, 2026
Get alerts when LAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days